Physician

Adam C Spiess, MD

According to 2025 Medicare claims, Adam Spiess, MD (NPI: 1770555179) practices otolaryngology in the Columbus, OH market, with the plurality of this provider's patient population coming from Franklin, OH. This provider's primary affiliated billing organization is UNIVERSITY OTOLARYNGOLOGISTS INC (NPI: 1750330551; TIN: 31-0682633) and primary practice location at 43081-8095.

Spiess' data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 843 traditional Medicare patients, billed 2,137 HCPCS/CPT codes, and received $213,953 in Medicare payments. The top billing code was 99204 (New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more). Part D data shows 2,390 prescription claims across 893 beneficiaries totaling $297,291 in drug costs, led by Xhance (Fluticasone Propionate). 2023 DME data shows 12 claims. Open Payments data shows 19 records totaling $620. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved sharply higher in recent years, from $116,633 to $297,291. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $1,072 and ending at $965.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	655	1,676	$145,515
2016	759	1,912	$161,194
2017	746	1,820	$153,076
2018	773	1,938	$160,975
2019	790	2,035	$186,796
2020	693	1,714	$145,003
2021	746	1,743	$157,116
2022	855	1,943	$174,634
2023	837	2,051	$189,985
2024	843	2,137	$213,953

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	534	1,850	$116,633
2016	541	1,865	$93,507
2017	527	1,649	$75,932
2018	596	1,913	$78,390
2019	657	2,054	$108,122
2020	630	1,937	$173,667
2021	707	2,254	$281,223
2022	775	2,217	$283,494
2023	803	2,283	$367,701
2024	893	2,390	$297,291

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	N/R	N/R
2023	N/R	12	$328
2024	N/R	N/R	N/R

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99204	New patient office or other outpatient visit with moderate level of medical decision making, if using time, 45 minutes or more	188	188	$105
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	265	377	$88
99203	New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more	152	152	$67
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	264	344	$61
69210	Removal of impacted ear wax	153	249	$30

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Xhance	Fluticasone Propionate	267	10,864	$251,675
Pantoprazole Sodium	Pantoprazole Sodium	500	42,309	$6,540
Ciprofloxacin-Dexamethasone	Ciprofloxacin Hcl/Dexameth	58	677	$6,528
Fluocinolone Acetonide Oil	Fluocinolone Acetonide Oil	138	3,814	$5,432
Dexlansoprazole Dr	Dexlansoprazole	13	990	$4,495

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	19	$620	Optinose US, Inc.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Adam C. Spiess, MD?

Tedicare shows public-source Medicare data for Adam C. Spiess, MD (NPI 1770555179), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Adam C. Spiess, MD have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Adam C. Spiess, MD?

Adam C. Spiess, MD is linked to UNIVERSITY OTOLARYNGOLOGISTS INC (billing NPI 1750330551) in the available physician profile data.

Does Adam C. Spiess, MD have Open Payments data?

Adam C. Spiess, MD has 19 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.